ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志

• 论文 • 上一篇    下一篇

足细胞靶向治疗激素抵抗性肾病综合征

  

  • 出版日期:2019-10-28 发布日期:2020-01-07

Podocytetarget therapy for steriodresistant nephrotic syndrome:from genetics mechanism to clinical management

  • Online:2019-10-28 Published:2020-01-07

摘要: 基于肾活检病理类型使用免疫抑制剂,是目前肾病综合征的常规治疗策略。然而因肾病综合征病因及发病机制的差异,临床实践中并没有“onesize fits all”的治疗手段:尽管应用多种免疫抑制剂后,仍约有50%的激素抵抗性肾病综合征(SRNS)患者可在10年内进展为终末期肾病。研究发现,肾脏足细胞基因异常可能在SRNS的发病机制中扮演重要角色,目前已发现70多个与足细胞发育、结构及代谢相关的基因可能与SRNS发病有关。伴随着对足细胞损伤机制认识的深入及以足细胞为主要治疗靶点的药物的研发,可能为SRNS患者个性化治疗提供新选择。

关键词: 肾病综合征, 激素抵抗, 局灶节段肾小球硬化症, 足细胞

Abstract: Currently,immunosuppressive therapy  based on pathological diagnosis from renal biopsy,has been accepting as routine algorithm for nephrotic syndrome.Unfortunately,there is no “ onesizefitsall” approach for precise patient stratification and treatment when facing the huge challenges posed by steroidresistant nephrotic syndrome(SRNS),children with SRNS undergoing renal biopsy do not respond to immunosuppressive therapy,and 50% of them will progress to endstage renal disease (ESRD) within 10 years.Extensive researches have proposed the podocyte as a crucial site of cellular injury in SRNS,and more than 70 genes are identified essential for podocyte development,structures and functions,which have been proved to play a key role in the pathogenesis of SRNS/FSGS (focal segmental glomeruloscelerosis).In future,The molecular ontology of SRNS in the era of NGS will ultimately help not only to uncover the pathogenic pathways,redefine diagnostic classification and prognostic assessment,but also to provide targets to guide the personalized medical management.

Key words: nephrotic syndrome, steriod-resistant, focal segmental glomerulosclerosis, podocyte